非酒精性脂肪性肝炎
医学
脂肪性肝炎
纤维化
肝纤维化
内科学
肝纤维化
胃肠病学
非酒精性脂肪肝
脂肪肝
疾病
作者
Michihiro Iwaki,Masato Yoneda,Naohiro Wada,Tomohiro Otani,Takashi Kobayashi,Asako Nogami,Satoru Saito,Atsushi Nakajima
标识
DOI:10.1080/14728214.2024.2328036
摘要
Approved drug therapies for nonalcoholic steatohepatitis (NASH) are lacking, for which various agents are currently being tested in clinical trials. Effective drugs for liver fibrosis, the factor most associated with prognosis in NASH, are important.
科研通智能强力驱动
Strongly Powered by AbleSci AI